| Company Name: |
ChemeGen |
| Tel: |
18818260767 |
| Email: |
2625930290@qq.com |
|
| | COX-2 (HUMAN) BLOCKING PEPTIDE Basic information |
| | COX-2 (HUMAN) BLOCKING PEPTIDE Chemical Properties |
| solubility | water: 10 mg/ml |
| | COX-2 (HUMAN) BLOCKING PEPTIDE Usage And Synthesis |
| Description | To be used in conjunction with Cayman’s COX-2 (human) Polyclonal Antibody (Item No. 160107) or the COX-2 (human) monoclonal antibodies (Item Nos. 160112 | 160113 | 160122) to block protein-antibody complex formation during immunochemical analysis for COX-2.WARNING This product is not for human or veterinary use. | | References | [1] JUSTYNA URBAN. Stromal, rather than epithelial cyclooxygenase-2 (COX-2) expression is associated with overall survival of breast cancer patients.[J]. BMC Cancer, 2014: 732. DOI: 10.1186/1471-2407-14-732
[2] PRADEEP BHANDARI. Prognostic significance of cyclooxygenase-2 (COX-2) expression in patients with surgically resectable adenocarcinoma of the oesophagus.[J]. BMC Cancer, 2006, 6: 134. DOI: 10.1186/1471-2407-6-134
[3] G P BOLAND. COX-2 expression is associated with an aggressive phenotype in ductal carcinoma in situ[J]. British Journal of Cancer, 2004, 90 2: 423-429. DOI: 10.1038/sj.bjc.6601534
[4] ARI RISTIMÄKI . Expression of Cyclooxygenase-2 in Human Transitional Cell Carcinoma of the Urinary Bladder[J]. American Journal of Pathology, 2001, 158 3: Pages 849-853. DOI: 10.1016/s0002-9440(10)64033-3 |
| | COX-2 (HUMAN) BLOCKING PEPTIDE Preparation Products And Raw materials |
|